In vitro DNA and dGMP adducts formation caused by ochratoxin A.

Area of Science:

• Toxicology
• Molecular Biology
• Biochemistry

Background:

• Ochratoxin A (OTA) is a nephrotoxic and nephrocarcinogenic mycotoxin.
• OTA administration in animals leads to DNA adduct formation, suggesting potential epigenetic effects.
• In vitro assays are crucial to distinguish direct DNA damage from indirect effects mediated by endogenous compounds.

Purpose of the Study:

• To investigate the in vitro metabolic activation of Ochratoxin A (OTA).
• To identify the specific DNA adducts formed and the target nucleotides.
• To elucidate the metabolic pathways involved in OTA's genotoxicity.

Main Methods:

• Incubation of salmon testes DNA with OTA using mouse or rabbit kidney and liver microsomes.
• Cofactors used included NADPH (cytochrome P450 pathway) and arachidonic acid (prostaglandin synthases/lipoxygenases).
• Detection of DNA adducts using the 32P postlabeling method; identification of modified nucleotides using dAMP, dGMP, dTMP, and dCMP.

Main Results:

• Significant DNA adduct formation (up to 126 adducts/10^9 nucleotides) was observed with kidney microsomes, particularly with arachidonic acid.
• Liver microsomes showed significantly lower adduct levels.
• Adducts were exclusively formed on guanine residues (dGMP), with three major adducts identified under both cofactor conditions.

Conclusions:

• Ochratoxin A is metabolized to genotoxic metabolites that directly interact with DNA.
• The results support the preferential activation of OTA by peroxidase activity (prostaglandin synthases/lipoxygenases) rather than cytochrome P450 pathways.
• These in vitro findings align with previous in vivo observations of OTA-induced DNA damage.